Hear ASTRO Leadership provide a summary year in review and strategic planning for the year ahead!

Date: Wednesday, October 28, 2026 - 6:00 pm Eastern time

Each year in the U.S., thousands of pregnant people will be diagnosed with cancer and face the need for radiotherapy.

In medical imaging and radiation oncology, image synthesis refers to generating a target image modality from a given source modality, for example, synthetic CT images from MRI simulations for treatment planning.

Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology.

Managing symptoms induced by radiotherapy is an important component of radiation oncology practice.

Palliative radiotherapy remains an unmet need, despite its efficacy. The presenter discusses how a dedicated palliative radiation service can address barriers to care and play an integral role in improving care access and receipt.

Radiation oncologists see patients across a wide spectrum of oncologic diseases and clinical conditions. Whether as a result of disease burden, cancer-directed treatment, or other unrelated problems, many patients present to radiation oncology clinic with significant symptom management needs.

Extended disruptions in treatment capabilities due to unforeseen events — such as cyberattacks or equipment failures — pose significant challenges for radiotherapy departments.

Surface guided radiation therapy (SGRT) is a widely adopted technology—used in more than 40% of U.S. radiation therapy clinics—and is now a cornerstone of efficient, high-quality treatment delivery and patient safety.

This activity is dedicated to unraveling the emerging field of focal therapies in oncology, with a specific focus on histotripsy, high-intensity focused ultrasound (HIFU) and electroporation.

Pages

Subscribe to RSS - General RO